NCIC

We are proud to celebrate all our and nurses today

Today for we launch Nurses of Peter Mac.

Read the extraordinary stories of the nurses who provide world leading care to our patients every single day of the year.

To every nurse at Peter Mac and across the globe, we thank you.

Visit www.nursesofpetermac.com to read about the Nurses of Peter Mac.

And, if you have a story or memory about our incredible nurses, leave a comment below.

Congratulations to our very own Dr Michelle Yong. A very well deserved award

https://twitter.com/i/status/1472831922397134851
ICYMI: The C-SMART trial is investigating another way - in addition to vaccines - to protect cancer patients from . The nasal spray trial is open to anyone with a past or current cancer diagnosis. Learn more: https://csmart.com.au

10 News First Melbourne on Twitter “A re-purposed nasal spray is being trialled to help prevent cancer patients from catching COVID-19 | https://t.co/VTvUv6vt6Y”

Visit csmart.com.au for more info https://www.couriermail.com.au/news/victoria/melbourne-researchers-looking-for-volunteers-to-trial-a-nasal-spray-aimed-at-preventing-covid/news-story/5422e221d248ea31e15261191ed0f2c8?btr=0e27e57a9c0e624fc5623aadc23583e2

Nasal spray’s incredible results against Covid All cancer patients so far treated with a Melbourne-developed nasal spray hoped to prevent Covid have avoided infection during several large waves of the pandemic this year.

You may also have seen or heard our nasal spray for COVID prevention in Cancer patients (CSMART) discussed on channel 10 news, Sky news, ABC radio or even Kiss FM! All cancer patients in VIC and NSW are eligible- for more info go to csmart.com.au

Nasal spray’s incredible results against Covid All cancer patients so far treated with a Melbourne-developed nasal spray hoped to prevent Covid have avoided infection during several large waves of the pandemic this year.

Now recruiting! c-smart.com.au a clinical trial of nasal spray COVID prevention for cancer patients

$5M grant to improve outcomes from infection To advance her work to improve infection outcomes in cancer patients, Professor Monica Slavin has received a $5 million Health Services Research Synergy grant from the NHRMC.

100 cancer patients successfully enrolled onto CSMART!!
We are investigating if a low dose of the drug Interferon-alpha (delivered as a daily nasal spray) can help to prevent COVID-19 and other viral respiratory infections. You can still be involved even if you have been vaccinated. Please contact the CSMART team https://www.csmart.com.au/ if you are interested. We are enrolling at multiple sites in Victoria and Westmead Hospital in Sydney.

C-SMART CLINICAL TRIAL Register here C-SMARTCOVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Controlled Trial The C-SMART clinical trial is investigating prevention options for COVID-19 and other viral respiratory infections in cancer patients.People living with cancer are more like...

Today we're talking for .

Do you know the signs and symptoms? If you or your loved one has an infection that’s not getting better or is getting worse, ACT FAST and seek medical care immediately.

Find out more: https://www.safetyandquality.gov.au/our-work/partnering-consumers/national-sepsis-program -for-consumers

If you're over 18 and have been treated for cancer (currently or previously) you could help our researchers with the C-SMART trial.

We are excited to be kicking off the second phase of this trial to further investigate whether a daily nasal spray can help protect cancer patients from respiratory viruses including COVID-19 and the flu.

Read more about the C-SMART trial, and how patients can join here:https://www.petermac.org/news/nasal-spray-could-help-prevent-viral-infections-cancer-patients

Now enrolling at PeterMac, Sydney's Westmead, Royal Melbourne Hospital, St V's Melbourne and the ONJ centre at the Austin. Visit www.csmart.com.au for more info

C-SMART CLINICAL TRIAL Register here C-SMARTCOVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Controlled Trial The C-SMART clinical trial is investigating prevention options for COVID-19 and other viral respiratory infections in cancer patients.People living with cancer are more like...

If you’ve experienced cancer and have had the jab, are thinking about getting it, or have decided it’s not right for you, and want to hear from you. Your voice matters. Take the survey: https://bit.ly/3fAiPr4

Monica Slavin and the NCIC team are running a trial of alternative COVID prophylaxis while we wait for a vaccine. Visit csmart.com.au for more info

Drugs for tapeworm, vertigo among possible COVID-19 treatments Australian researchers are among global efforts to develop potential treatments as the world waits for a comprehensive vaccine rollout.

A BIG THANK YOU to all the patients who have registered to take part in our C-SMART trial which is investigating if a low dose of a drug delivered as a daily nasal spray can help prevent COVID-19 and other viral respiratory infections.

We still need more patients aged 18 years and over who have had cancer treatment within the past year to take part in this important trial by Peter Mac and NCIC.

Prevention and treatment options for COVID-19 infection are urgently required for cancer patients, who often have a weakened immune system.

We are so grateful to all those participating in this trial and to our dedicated team of infectious diseases experts (pictured).

If you are interested in taking part in this trial or would like to find out more, please visit www.csmart.com.au.

NCICs current trial- head to csmart.com.au for more info

We are currently recruiting patients to participate in a clinical trial to test whether daily use of a medicated nasal spray can provide protection against COVID-19 and other viral infections.

To participate in the trial, patients should be aged 18 years and over and have had cancer treatment within the past year.

Read more about the C-SMART trial and find out if you're eligible here: https://www.petermac.org/news/protecting-our-most-vulnerable-covid-19 or head to the C-SMART website: www.csmart.com.au

A clinical trial is now underway at Peter Mac to test whether a daily nasal spray can help protect cancer patients from viruses including COVID-19. Read more about the C-SMART trial, and how patients can join, here:
https://www.petermac.org/news/protecting-our-most-vulnerable-covid-19

https://twitter.com/PeterMacHSR/status/1336895909771153408?s=20 Congratulations to NCICs first ever Nurse Practitioner Belinda Lambros!! Belinda has been working towards this role for the last 12 years and we couldn't be more proud to have supported her and her fantastic AMS work.

Peter Mac Health Services Research on Twitter “A wonderful example of successful health services research. Meet Belinda Lambros, our newly minted nurse practitioner in infectious diseases and antimicrobial stewardship: this role was developed as a research collaboration between and ”

Very proud of the work of NCIC lead A/Prof Leon Worth during the COVID 19 pandemic.

Sunday was - an important day to highlight this common cause of death across the globe.

We're joining hospitals across the world to raise awareness.

Globally, sepsis affects between 47 and 50 million people every year and is it's the cause of 20 per cent of all deaths worldwide.

often presents as the clinical deterioration of common and preventable infections such as those of the respiratory, gastrointestinal and urinary tract, or of wounds and skin.

Sepsis is potentially reversible if it's diagnosed at an early stage, so it's important to know the risks, spot the signs and act fast.

Our Infectious Diseases and Infection Prevention teams are raising awareness today with a special online seminar for medical staff.

Don't delay your cancer screening - Dr Brett Sutton Cancer Screening Programs. Hi, I’m Brett Sutton – the Chief Health Officer for Victoria. We’ve been asking Victorians to help slow the spread of coronavirus ...

THE PROTREAT CLINICAL SMART TRIAL FOR PREVENTION AND TREATMENT OF COVID-19 IN CANCER
Cancer patients are highly vulnerable and at risk of COVID-19 infection. NCIC along with the Victorian Comprehensive Cancer Centre and the Peter MacCallum Cancer Centre will be running a clinical trial specifically for cancer patients: preventing COVID-19 with a safe and well tolerated antivirus nose spray that has shown good results overseas against COVID-19; and treatment of moderate to severe COVID-19 with exciting new drugs developed right here in Melbourne, Australia. The SMART design of our study will mean that we will continually monitor the effects on cancer patients and most importantly will provide reassurance that we are doing everything we can to support them in their cancer fight.

NCIC manager Dr Megan Crane today awarded the weekly Peter mac DIVOC-91 award for her contribution to PeterMac’s reversing the trend!!!

Peter Mac COVID-19 case a 'false positive' Last night, we were relieved to learn that a staff member, who earlier this week tested positive for COVID-19, was actually a ‘false positive’.

If you’re in Victoria and worried about , our self-assessment tool will help you better understand the risk based on your personal circumstances. https://www.dhhs.vic.gov.au/coronavirus-self-assessment

Unless you fall into one of the at-risk groups you don't need to be tested at an assessment centre or general practice

Check if you fit criteria: https://www.dhhs.vic.gov.au/victorian-public-coronavirus-disease-covid-19 Guidelines also available for healthcare/residential care workers

You can call 1800 675 398 for advice 24/7

Wondering if you need to get tested for ?
Use our self-assessment flowchart to find out.

Download and print for your work, business, school or community:
https://www.dhhs.vic.gov.au/victorian-public-coronavirus-disease-covid-19

For the latest reliable information visit www.dhhs.vic.gov.au/coronavirus

is a rapidly changing situation. Please visit for regular updates and reliable advice: https://www.dhhs.vic.gov.au/coronavirus

Peter Mac is working closely with the Victorian Department of Health and Human Services to keep safe and protect our patients and their families & carers, visitors and health care workers from COVID-19.

Please read this important update on our website: https://www.petermac.org/news/information-about-coronavirus-covid-19

Please follow your local state health department advice for all health warnings
Peter MacCallum Cancer Centre

Infection can spread after close contact with an infectious person, and touching contaminated surfaces.

Help prevent the spread of infection through good hygiene: practice not touching your face and washing your hands regularly for 20 seconds.

Read more about what you can do: https://www.dhhs.vic.gov.au/coronavirus

A massive congratulations to Peter Mac’s Professor Monica Slavin, Professor Karin Thursky, Professor Gail Risbridger and Associate Professor Prue Francis who have been elected as Fellows of the Australian Academy of Health and Medical Sciences.

They are four of the 19 women out of the 40 new Ordinary Fellows in the 2019 induction.

Read more: https://www.petermac.org/news/peter-mac-researchers-and-clinicians-elected-fellows-aahms

Dame Kate Campbell Fellowships awarded to Peter Mac researchers Prof Sarah-Jane Dawson, Prof Mark Dawson and Prof Karin Thursky have been awarded prestigious Dame Kate Campbell Fellowships from The University of Melbourne in recognition of outstanding research performance.